Clinical trial
A Randomised, Double-blind, Placebo Controlled, Parallel Group, Multi-centre, Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee
NCT02997696 is registered in ClinicalTrials.gov with Ono Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Double-blind, Placebo Controlled, Parallel Group, Multi-centre, Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee
- Lead sponsor
- Ono Pharmaceutical Co., Ltd.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 31, 2017
- Completion date
- January 9, 2018
- Enrollment
- 70 (actual)
- Sites
- 47
Conditions
As the registry lists them; a condition with its own page is linked.